Medication do not crush list: Reference sheet for nurses

A medication do not crush list names the oral drugs that must be swallowed whole, and the reason each one is unsafe to alter. Crush the wrong tablet and a full day’s dose can hit the bloodstream in minutes. Other tablets lose the coating that shields the stomach, and some release powder a nurse should never be breathing.

Five formulation types account for almost every entry: extended-release, enteric-coated, cytotoxic, narrow therapeutic index, and sublingual or buccal. Each category below gives the marker on the label, the safer form to request, and the reason behind the restriction.

Key takeaways

Extended-release medications (ER, XR, SR, XL, LA, CD) must never be crushed. Crushing dumps the whole dose at once instead of releasing it over hours, which risks toxicity.

Enteric coatings shield the stomach, or hold a drug back until it reaches the intestine. Crushing removes that protection, so the drug either irritates the stomach or stops working.

Narrow therapeutic index is not the same as do not crush. Digoxin and warfarin tablets are crushed routinely, while phenytoin’s extended-release capsule is not.

A published list is a starting point, and the package insert settles the individual case. Check each medication before administration, then call the pharmacist when a patient cannot swallow it whole.

Most do-not-crush medications have a safer form: a liquid, a dispersible tablet, a transdermal patch, or a sprinkle capsule. Request it from the pharmacy or the prescriber.

What a medication do not crush list is, and who reaches for it

A medication do not crush list is a clinical safety reference that names the oral medications unsafe to crush. Each entry carries the pharmacological reason behind the restriction.

Nurses, pharmacists, and caregivers treat it as a bedside check before a dose leaves the cart. It earns its place with patients who have dysphagia, an enteral feeding tube, or cognitive impairment.

Most teams keep a printed copy at the medication cart and another in the patient’s file. Screening digitally gets the warning in front of staff earlier. Digital intake forms can record swallowing difficulty at admission, so the flag reaches the medication record ahead of the first dose.

Five hazards that put a drug on the list

Every entry traces back to one of five clinical hazards. Knowing which one applies tells you what to ask the pharmacy for.

• Dose dumping: extended-release tablets meter the drug out over hours, and crushing delivers the whole amount at once. Acute toxicity or overdose follows.
• Loss of stomach protection: enteric coatings dissolve in the small intestine. Crush one and a caustic drug reaches the gastric lining unprotected.
• Caregiver and environmental exposure: cytotoxic and teratogenic drugs become airborne powder when crushed, which puts the person preparing the dose at risk.
• Narrow therapeutic margin: phenytoin’s extended-release capsule leaves little room between a working blood level and a toxic one, so a sudden spike matters.
• Loss of route-specific absorption: sublingual and buccal tablets absorb through the oral mucosa. Swallow the powder and that advantage disappears.

Those five hazards map onto five formulation types, and each one leaves a marker on the packaging. The table below pairs the marker with the safer form to request.

Extended-release tablets deliver a full day’s dose in minutes

Extended-release drugs are engineered to dissolve slowly across 12, 24, or 48 hours. Crushing bypasses that mechanism completely, and the result is dose dumping. The bloodstream sees a concentration the body was never meant to handle in one go.

• ER, XR, SR, XL: extended, long-acting, or sustained-release formulations, used across most drug classes.
• LA, CD: long-acting or controlled-delivery systems, common in cardiovascular and psychiatric medications.
• Familiar examples: Toprol XL (metoprolol), Sinemet CR (carbidopa/levodopa), Depakote ER (valproate), OxyContin (oxycodone), Effexor XR (venlafaxine).

Crushing a 100 mg Toprol-XL tablet delivers in minutes what the release matrix would spread across a full day. Acute hypotension, bradycardia, or shock can follow.

Catching it depends on the formulation type being visible at the point of administration, which is why medical records management matters here. Client records that store the formulation beside the drug name give staff the warning before the crusher comes out.

Enteric coatings only work while the tablet stays whole

An enteric coating is a polymer layer that dissolves in the neutral pH of the small intestine, not in the stomach. It protects two kinds of drugs.

The first group irritates the gastric lining, such as NSAIDs and aspirin. The second group is destroyed by stomach acid, such as pancreatic enzymes and certain antibiotics.

• Enteric-coated NSAIDs: ibuprofen EC, naproxen EC, and indomethacin ER, all coated to keep acid irritation away from the gastric mucosa.
• Acid-labile drugs: omeprazole, lansoprazole, and pantoprazole, where delayed-release technology is what gets the drug past stomach acid intact.
• Enzyme preparations: pancreatin and lipase tablets, which lose their activity at gastric pH without the coating.

Crush one of these and the coating is gone instantly. NSAIDs then reach the gastric mucosa unprotected, which can cause ulceration or bleeding. Acid-labile drugs are simply inactivated, so the patient takes a dose with no effect. Note the instruction to swallow whole at each medication review, because it tends to be the detail a new caregiver misses.

Hazardous drugs and narrow margins follow their own rules

Two high-risk groups sit slightly apart from the formulation categories above. One is about protecting the person giving the dose. The other is about how little room there is for error in the blood level.

Cytotoxic and teratogenic drugs put the caregiver at risk

Chemotherapy agents, immunosuppressants, and some antiretrovirals are hazardous to handle. Crushing them into powder creates an inhalation risk for the caregiver, plus a dermal absorption risk if particles reach skin or mucous membranes.

USP General Chapter <800> standards govern hazardous drug handling in healthcare settings, and crushing is prohibited outside a certified containment device.

Narrow therapeutic index drugs are not all off limits

Narrow therapeutic index (NTI) drugs leave a small margin between a therapeutic dose and a toxic one. That earns them close monitoring, but it does not automatically make them do-not-crush. The formulation decides, and it varies by drug.

• Phenytoin: the extended-release capsule is the genuine do-not-crush case here. Opening or crushing it dumps the dose and risks central nervous system toxicity.
• Digoxin: supplied as a plain immediate-release, uncoated tablet, and crushed routinely in practice. Dose accuracy and serum monitoring are the concerns, not dose dumping.
• Warfarin: also an immediate-release uncoated tablet. Crushing is common, so the priority is capturing the full dose and keeping INR checks on schedule.

The practical takeaway is to check the form rather than the drug class. A blanket ban on crushing every NTI drug sends staff to the pharmacist for doses that were never a problem.

Crushing a sublingual tablet throws away the whole point

Sublingual and buccal tablets dissolve under the tongue or against the inner cheek. The drug absorbs straight through the oral mucosa and skips first-pass metabolism in the liver. That is what makes the onset fast enough for acute symptoms.

• Sublingual examples: nitroglycerin (angina), isosorbide dinitrate (angina), lorazepam (acute anxiety).
• Buccal examples: fentanyl (Fentora) and buprenorphine (Belbuca).

A crushed sublingual tablet gets swallowed into the GI tract, where it meets first-pass metabolism and slower absorption. Onset is delayed, and peak levels may never reach the therapeutic range at all. With nitroglycerin for chest pain, that delay is the difference between relief and an emergency.

Safer forms to ask the pharmacy for

A patient who cannot swallow a tablet whole needs a different form, not a workaround. Five alternatives cover most situations, and the pharmacy or prescriber can arrange any of them.

• Liquid formulations: oral solutions, suspensions, and syrups let you measure the dose by volume, and they suit every patient group.
• Dispersible or effervescent tablets: these dissolve in water and can be given by cup or syringe. They are not the same as a crushable tablet, so confirm with the pharmacist.
• Sprinkle capsules: some extended-release capsules, Depakote Sprinkle among them, open onto soft food. Do this only where the package insert says so explicitly.
• Transdermal patches: where a skin-delivered version exists, such as fentanyl, scopolamine, or nicotine, the patch removes the swallowing problem altogether.
• Compounded preparations: a licensed pharmacy can make a custom liquid or capsule. Cost and turnaround usually restrict this to longer-term arrangements.

One practical note on timing. Ask for the alternative when the swallowing problem is first documented, not at the next medication pass. Compounding and stock orders both take days.

The check to run before anyone reaches for a crusher

Four steps, in order, every time the question comes up.

1. Check the medication record against the do-not-crush sheet. At every medication pass, confirm whether the drug appears on your facility’s sheet or its restricted-medication list. Practice software should surface the flag without anyone going to look for it.
2. Read the package insert. The prescribing information states whether crushing is permitted, and it names the approved alternative forms. It settles cases the sheet cannot.
3. Call the pharmacist. Where you are unsure, or the patient cannot take the form as prescribed, contact the pharmacy first. The pharmacist can authorize a therapeutic substitution, such as a switch from extended-release to immediate-release, or suggest another form.
4. Document the reason and the form given. Record why the standard form was unsuitable, who authorized the change, and what the patient actually received. A medication log template keeps that trail in one place across shifts.

Three mistakes that surface on medication audits

• Crushing after a verbal go-ahead. The pharmacist approved it, but nobody wrote it down, so the next shift has no authorization on file.
• Treating a brand switch as the same drug. A generic can arrive in a different formulation, and an immediate-release tablet last month may be extended-release today.
• Assuming a tube changes the rules. Enteral administration has its own guidance, and a drug that cannot be crushed for oral use is not automatically safe down a tube.

Where the swallowing difficulty is going to continue, tell the prescriber early. Prescription software that carries the administration flag through to the next refill saves the same conversation happening every month.

Long-term care raises the stakes on every medication pass

Nursing homes, assisted living, and skilled nursing facilities carry the highest concentration of at-risk residents. Swallowing difficulty, feeding tubes, and cognitive impairment are common, and medication rounds are long. Five controls do most of the work.

• Dysphagia screening: identify residents with swallowing difficulty at admission, then flag their medication profiles for do-not-crush review.
• Medication reconciliation: at admission and at every order change, check the prescribed drug against the sheet and request alternatives up front.
• Enteral tube administration: tube rules differ from oral rules. Some drugs that cannot be crushed for oral use can be given safely by tube in another form. Confirm with the pharmacist and the insert.
• Staff training: CMS regulations require competency in medication administration. Every person giving medications needs the concept and a current copy of the sheet.
• Pharmacist review: a consultant pharmacist should work through resident profiles monthly and flag do-not-crush drugs with an available alternative.

CMS compliance surveys look at medication administration safety directly. Documented do-not-crush reviews are the evidence that the program is working rather than written down somewhere.

How to put the reference sheet to work in your practice

The downloadable sheet is a pre-structured form, ready to customize and print. Six steps get it into daily use.

1. Download the PDF. It is a one-page landscape sheet covering 16 medications across the five risk categories, with blank rows at the bottom for your own additions.
2. Adjust the column headings. The default columns are Drug Name, Strength, Formulation Type (ER/XR/EC/SL), Reason Not to Crush, Safe Alternatives, and Pharmacist Approval Required.
3. Match it to your formulary. Add the do-not-crush drugs your team gives most often, and remove the ones you never stock. A shorter, accurate sheet gets read.
4. Post it where doses are prepared. Laminate copies for the medication room, the cart, and the nursing station. Review it quarterly, or sooner if prescribing information changes.
5. Connect it to your records. Practices running digital medication records can attach the sheet to the patient’s medication profile, or store it as a facility-wide policy document.
6. Train everyone who administers. Nurses, pharmacy technicians, and caregivers all need it, so build it into orientation. Pair it with a drug card template for the drugs new staff handle most.

Where do-not-crush guidance actually comes from

The list of oral dosage forms that should not be crushed is a widely used clinical reference. Pharmacist John Mitchell compiled the original, and the Institute for Safe Medication Practices (ISMP) circulated it for years. ISMP has since stated that it does not own, update, or review that list.

That matters for how much weight you put on a copy found online. ISMP still publishes medication-safety alerts and error-prevention guidance, and those remain worth following. For a specific crushing decision, the deciding source is the product’s FDA labeling, confirmed with your reviewing pharmacist.

Keep a written sheet of your own, review it on a schedule, and fold new safety alerts into your medication protocols. Three other sources carry authority here. FDA drug labeling specifies crushing restrictions product by product. USP standards for oral dosage forms and Joint Commission medication safety standards set the wider expectations.

How Pabau keeps the do-not-crush check in the medication record

A printed sheet only helps when someone stops to read it. Practice management software like Pabau puts the same warning on the patient’s own record, where the nurse is already working.

Swallowing difficulty, feeding tube status, and the pharmacist’s instructions are recorded once on the client card. Custom intake forms capture the dysphagia screen at admission. The medical record then holds the authorization for any alternative formulation, so the next shift inherits the decision instead of remaking it.

Recurring tasks keep the review on schedule. Assign the quarterly formulary check to your consultant pharmacist, and the reminder arrives without anyone tracking dates in a spreadsheet. The completed task stays in the record as evidence for a CMS survey.

Keep medication safety flags in the record

Pabau records swallowing difficulty, feeding tube status and pharmacist authorizations on the patient’s own file, so the do-not-crush check reaches staff at the medication pass. Quarterly formulary reviews run as recurring tasks with an audit trail.

Book a demo

Conclusion

Knowing the five categories is the easy part. The hard part comes months later, on a busy round, when the warning has to reach the person actually holding the tablet. A laminated sheet does half that job. The patient’s record does the other half, telling staff at the moment of administration that this dose needs a different form.

Get the two working together and the pharmacist call stops being a delay and becomes routine. Download the sheet, trim it to the drugs your team actually gives, and set a quarterly review so it stays current as your formulary changes.

Would you rather the flag lived in the record than on the wall? Book a demo and see how Pabau keeps medication safety notes with the patient they belong to.

Continue your research

List Item #1

List Item #2

Frequently asked questions